Blirt

Gdansk, Poland Founded: 2008 • Age: 18 yrs Acquired By Qiagen
Specialty enzymes for nucleic acid purification and sequencing are produced.
Request Access

About Blirt

Blirt is a company based in Gdansk (Poland) founded in 2008 by Marian Popinigis was acquired by Qiagen in May 2022.. Blirt offers products and services including Proteinase K and RNase Inhibitor. Blirt operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.

  • Headquarter Gdansk, Poland
  • Founders Marian Popinigis
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Blirt S.A.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Qiagen

    (May 11, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Blirt

Blirt offers a comprehensive portfolio of products and services, including Proteinase K and RNase Inhibitor. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

High-demand enzyme for protein digestion in molecular biology assays

Protects RNA from degradation during biological research applications

Funding Insights of Blirt

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Blirt

Blirt has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Products and reagents for molecular diagnostic assays are supplied.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Blirt

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Blirt

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Blirt Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Blirt

Blirt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
domain founded_year HQ Location
Developer of cell culture media and ancillary reagents for life science research
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Develops tools and products for research and clinical application
domain founded_year HQ Location
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Blirt

Frequently Asked Questions about Blirt

When was Blirt founded?

Blirt was founded in 2008.

Where is Blirt located?

Blirt is headquartered in Gdansk, Poland. It is registered at Gdansk, Pomeranian Voivodeship, Poland.

Who is the current CEO of Blirt?

Piotr Lassota is the current CEO of Blirt.

What does Blirt do?

BLIRT was established in 2008 in Gdansk, Poland, within the biotechnology sector. Specialty enzymes used in nucleic acid purification and sequencing are manufactured by the company. Molecular biology kits are supplied alongside these products. Protein production services are offered, encompassing the design of expression systems for commercial applications. Operations remain focused on enzyme and kit development in Europe.

Who are the top competitors of Blirt?

Blirt's top competitors include Abcam, Sino Biological and Meridian Bioscience.

What products or services does Blirt offer?

Blirt offers Proteinase K and RNase Inhibitor.

Who are Blirt's investors?

Blirt has 1 investor. Key investors include Qiagen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available